BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17653896)

  • 1. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
    Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
    Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids.
    Besig S; Voland P; Baur DM; Perren A; Prinz C
    Neuroendocrinology; 2009; 90(4):402-15. PubMed ID: 19816005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids.
    Andersson E; Swärd C; Stenman G; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2009 Sep; 16(3):953-66. PubMed ID: 19458023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker.
    Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA
    Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.
    Goto K; Kodama T; Matsuno Y; Yokose T; Asamura H; Kamiya N; Shimosato Y
    Mod Pathol; 2001 Oct; 14(10):985-94. PubMed ID: 11598168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and prognostic factors in patients with small bowel carcinoid tumour.
    Landerholm K; Zar N; Andersson RE; Falkmer SE; Järhult J
    Br J Surg; 2011 Nov; 98(11):1617-24. PubMed ID: 21858790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of cyclooxygenase-2 as a prognostic biomarker in mid-gut carcinoid tumours.
    Cadden I; Johnston BT; Turner G; McCance D; Ardill J; McGinty A
    Neuroendocrinology; 2007; 86(2):104-11. PubMed ID: 17700013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.